Tectonic Therapeutic, Inc. (TECX)Healthcare | Biotechnology | Watertown, United States | NasdaqGM
34.34 USD
-0.03
(-0.087%) ⇩
(July 13, 2026, 4 p.m.
EDT)
|
Hot Take ↕ | July 11, 2026, 4:03 a.m. EDT
The fundamental reality here is stark: this biotech stock has suffered a catastrophic multi-year decline, dropping nearly 93% over the last seven years. Despite recent quarterly gains, the company remains in a deep hole with negative earnings, negative free cash flow, and a lack of dividends. The balance sheet is fragile, burning cash without the revenue to sustain it long-term. However, the options chain tells a different story for the immediate future. There is a distinct 'lottery ticket' setup brewing, with heavy call buying at the $45 level for late-year expirations. This suggests the market is pricing in a specific, high-stakes clinical trial result (Phase 2) that could double or triple the stock price if successful. If that trial fails, the deep put positions suggest a crash back to the $15 range. For a long-term investor, the fundamentals are broken; for a short-term trader, this is a high-risk, high-reward bet on a single upcoming data point. |
| Model | MAE |
|---|---|
| AutoTheta ✓ | 0.059228 |
| AutoETS | 0.059437 |
| AutoARIMA | 0.059624 |
| MSTL | 0.064232 |
| MSTL_84 | 0.068636 |
| MSTL_84_126 | 0.103717 |
| MSTL_126 | 0.104190 |
Forecast horizon: 60 days | Selected: AutoTheta
| Forecast Reliability | |
|---|---|
| Score | 25% |
| H-stat | 2.91 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.000 |
| Excess Kurtosis | 1.20 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 2.011 |
| Market Cap | 647,967,872 |
| Forward P/E | -7.34 |
| Beta | 0.10 |
| Website | https://tectonictx.com |
As of July 11, 2026, 4:03 a.m. EDT: Speculators are positioning for a binary event rather than a steady trend. Call Open Interest is heavily concentrated at the $45 strike for September and December expirations, suggesting a belief in a significant upside catalyst (likely a Phase 2 readout) that could push the price toward $45+. Conversely, Put Open Interest is stacked at deep strikes ($15-$25) for December and January, indicating a hedge against failure or a 'catapult' trade where traders are betting on a massive drop if the catalyst fails. The extremely low implied volatility for near-term September calls suggests the market expects the stock to remain flat until the catalyst hits, at which point volatility will likely spike.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.6016791 |
| Address1 | 490 Arsenal Way |
| Address2 | Suite 210 |
| All Time High | 644.4 |
| All Time Low | 1.4 |
| Ask | 41.99 |
| Ask Size | 2 |
| Audit Risk | 6 |
| Average Analyst Rating | 1.1 - Strong Buy |
| Average Daily Volume10 Day | 251,670 |
| Average Daily Volume3 Month | 205,650 |
| Average Volume | 205,650 |
| Average Volume10Days | 251,670 |
| Beta | 0.098 |
| Bid | 24.48 |
| Bid Size | 2 |
| Board Risk | 7 |
| Book Value | 12.236 |
| City | Watertown |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Compensation Risk | 9 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 34.34 |
| Current Ratio | 18.513 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,782,777,600 |
| Day High | 34.9 |
| Day Low | 32.2851 |
| Debt To Equity | 2.011 |
| Display Name | Tectonic Therapeutic |
| Earnings Timestamp | 1,778,184,000 |
| Earnings Timestamp End | 1,786,046,400 |
| Earnings Timestamp Start | 1,786,046,400 |
| Ebitda | -91,720,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -4.532 |
| Enterprise Value | 415,706,848 |
| Eps Forward | -4.68 |
| Eps Trailing Twelve Months | -4.46 |
| Esg Populated | 0 |
| Exchange | NGM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 30.3492 |
| Fifty Day Average Change | 3.9908009 |
| Fifty Day Average Change Percent | 0.13149609 |
| Fifty Two Week Change Percent | 60.167908 |
| Fifty Two Week High | 39.53 |
| Fifty Two Week High Change | -5.1899986 |
| Fifty Two Week High Change Percent | -0.13129266 |
| Fifty Two Week Low | 14.39 |
| Fifty Two Week Low Change | 19.95 |
| Fifty Two Week Low Change Percent | 1.3863795 |
| Fifty Two Week Range | 14.39 - 39.53 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,529,587,800,000 |
| Float Shares | 10,061,805 |
| Forward Eps | -4.68 |
| Forward P E | -7.337607 |
| Free Cashflow | -44,697,248 |
| Full Exchange Name | NasdaqGM |
| Full Time Employees | 60 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Governance Epoch Date | 1,782,864,000 |
| Gross Margins | 0.0 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.39337003 |
| Held Percent Institutions | 0.74109 |
| Implied Shares Outstanding | 18,869,186 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,718,928,000 |
| Last Split Factor | 1:12 |
| Long Business Summary | Tectonic Therapeutic, Inc., a biotechnology company, focuses on the discovery and development of therapeutic proteins and antibodies to modulate the activity of G protein coupled receptors (GPCRs). It develops GEODe technology platform to enable the discovery and development of GPCR-targeted biologic medicines. The company's lead product is TX45, a Fc-relaxin fusion molecule that activates the RXFP1 receptor, the GPCR target of the hormone, and relaxin. It is also developing TX2100 for the treatment of hereditary hemorrhagic telangiectasia; GPCR modulator bispecific for treating fibrosis; and other GPCR modulators. The company is headquartered in Watertown, Massachusetts. |
| Long Name | Tectonic Therapeutic, Inc. |
| Market | us_market |
| Market Cap | 647,967,872 |
| Market State | PRE |
| Max Age | 86,400 |
| Message Board Id | finmb_711440557 |
| Most Recent Quarter | 1,774,915,200 |
| Net Income To Common | -83,486,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 647,967,847 |
| Number Of Analyst Opinions | 9 |
| Open | 33.95 |
| Operating Cashflow | -65,408,000 |
| Operating Margins | 0.0 |
| Overall Risk | 8 |
| Payout Ratio | 0.0 |
| Phone | 339 666 3320 |
| Pre Market Change | 0.0 |
| Pre Market Change Percent | 0.0 |
| Pre Market Price | 34.34 |
| Pre Market Time | 1,784,026,809 |
| Previous Close | 34.37 |
| Price Hint | 2 |
| Price To Book | 2.8064728 |
| Profit Margins | 0.0 |
| Quick Ratio | 18.282 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.1 |
| Region | US |
| Regular Market Change | -0.0299988 |
| Regular Market Change Percent | -0.0872819 |
| Regular Market Day High | 34.9 |
| Regular Market Day Low | 32.2851 |
| Regular Market Day Range | 32.2851 - 34.9 |
| Regular Market Open | 33.95 |
| Regular Market Previous Close | 34.37 |
| Regular Market Price | 34.34 |
| Regular Market Time | 1,783,972,801 |
| Regular Market Volume | 147,850 |
| Return On Assets | -0.20716 |
| Return On Equity | -0.31418 |
| Sand P52 Week Change | 0.20365608 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Share Holder Rights Risk | 8 |
| Shares Outstanding | 18,869,186 |
| Shares Percent Shares Out | 0.113199994 |
| Shares Short | 2,136,671 |
| Shares Short Previous Month Date | 1,780,012,800 |
| Shares Short Prior Month | 2,341,074 |
| Short Name | Tectonic Therapeutic, Inc. |
| Short Percent Of Float | 0.2377 |
| Short Ratio | 15.21 |
| Source Interval | 15 |
| State | MA |
| Symbol | TECX |
| Target High Price | 101.0 |
| Target Low Price | 60.0 |
| Target Mean Price | 78.44444 |
| Target Median Price | 80.0 |
| Total Cash | 236,894,000 |
| Total Cash Per Share | 12.555 |
| Total Debt | 4,633,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -4.46 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 24.35155 |
| Two Hundred Day Average Change | 9.988451 |
| Two Hundred Day Average Change Percent | 0.41017723 |
| Type Disp | Equity |
| Volume | 147,850 |
| Website | https://tectonictx.com |
| Zip | 2,472 |